BeStock  
Stocks › Biotechnology › MBX

MBX Biosciences MBX

US equityMarket cap rank #2559Biotechnology
$49.55 −$3.86 (-7.23%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $49.55 0.00%
Open$53.48
Prev close$53.41
Day range$49.36 – $54.43
Volume581.9K
Market cap$2.46B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership117.3%-0.30 pts vs. prior quarter
Institutions holding221+13 vs. prior quarter
Insider trades (recent)30 buys / 19 sellsNet buying
Short interest8.90% of floatDays to cover 7.9 · as of 30 Oct 2026
Short-sale volume share24.8%5-day average of daily volume

Short-sale volume as % of daily volume

8%16%24%32%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$2.86M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$2.1MSuper−$745.5KBig−$2.5MMid−$4.5MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 52.5% of shares outstanding.

Largest holders

  • FMR14.84%
  • Frazier Life Sciences Management, LP13.40%
  • Wellington Management Group10.02%
  • New Enterprise Associates, Inc.7.28%
  • BlackRock6.99%
  • OrbiMed Advisors LLC6.19%
  • Paradigm Biocapital Advisors LP5.05%
  • NVP Associates, LLC4.30%

By investor type

  • Mutual Fund57.72%
  • VC/PE Fund35.97%
  • Hedge Fund20.40%
  • Individual/Insider2.64%
  • Public Company2.32%
  • Insurance Company0.33%
  • Government Pension Fund0.25%
  • Private Company0.17%

Reported short interest has fallen from 10.28% to 8.90% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +2,045,513 14.8%
BlackRock Mutual Fund 2026/Q3 +149,775 7.0%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +93,383 0.3%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +90,963 0.2%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +67,971 1.7%
Sowell Financial Services, LLC Mutual Fund 2026/Q3 +53,077 0.1%
Barclays PLC Public Company 2026/Q3 +50,503 0.3%
Franklin Resources Mutual Fund 2026/Q3 +40,552 0.6%
Paradigm Biocapital Advisors LP Hedge Fund 2026/Q3 +2,508,015 5.1%
FMR Mutual Fund 2026/Q3 +2,386,164 11.1%
Wellington Management Group Mutual Fund 2026/Q3 +1,785,699 10.0%
BlackRock Mutual Fund 2026/Q3 +382,266 6.9%
Marshall Wace LLP Hedge Fund 2026/Q3 +339,182 0.8%
Soleus Capital Management, L.P. Hedge Fund 2026/Q3 +336,382 1.0%
Bank of America Corporation Public Company 2026/Q3 +270,177 0.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 Steven Hoerter Executive Chairperson, CEO & President Open Market Disposition -4,893 $54.82 27,045
3 Nov 2026 Salomon Azoulay Chief Medical Officer Open Market Disposition -373 $53.96 1,839
19 Oct 2026 Peter Radovich Other Derivative Acquisition +18,200 $53.50 18,200
16 Aug 2026 Peter Hawryluk Former Officer Intent to Sell (Form 144) -3,745 $68.29 –
3 Aug 2026 Peter Hawryluk Former Officer Intent to Sell (Form 144) -936 $65.77 –
3 Aug 2026 Salomon Azoulay Chief Medical Officer Open Market Disposition -370 $65.77 14,399
2 Aug 2026 John Smither Chief Financial Officer Other Acquisition +28,000 – 28,000
2 Aug 2026 John Smither Chief Financial Officer Other Derivative Acquisition +130,000 $64.41 130,000
2 Aug 2026 Steven Hoerter Executive Chairperson, CEO & President Other Acquisition +71,000 – 82,938
2 Aug 2026 Steven Hoerter Executive Chairperson, CEO & President Other Derivative Acquisition +331,000 $64.41 331,000
9 Jun 2026 Richard Bartram Former Chief Financial Officer Intent to Sell (Form 144) -9,167 $30.55 –
8 Jun 2026 Richard Bartram Former Chief Financial Officer Intent to Sell (Form 144) -10,833 $29.66 –
3 Jun 2026 Patrick Heron Independent Director Other Derivative Acquisition +12,500 $30.91 12,500
3 Jun 2026 Edward Mathers Independent Director Other Derivative Acquisition +12,500 $30.91 12,500
3 Jun 2026 Ora Pescovitz Independent Director Other Derivative Acquisition +12,500 $30.91 12,500
3 Jun 2026 Tiba Aynechi Independent Director Other Derivative Acquisition +12,500 $30.91 12,500
3 Jun 2026 Steven Ryder Independent Director Other Derivative Acquisition +12,500 $30.91 12,500
3 Jun 2026 Steven Hoerter Executive Chairperson, CEO & President Other Derivative Acquisition +12,500 $30.91 12,500
3 Jun 2026 Laurie Stelzer Independent Director Other Derivative Acquisition +12,500 $30.91 12,500
12 May 2026 Richard Bartram Former Chief Financial Officer Intent to Sell (Form 144) -15,000 $36.95 –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 4,285,299 8.9% 7.9
15 Oct 2026 4,422,964 9.2% 7.5
30 Sep 2026 4,466,280 9.3% 6.8
15 Sep 2026 4,129,859 8.6% 11.4
31 Aug 2026 4,155,572 8.6% 10.1
14 Aug 2026 4,950,102 10.3% 11.2

Discussion

No comments yet — be the first to weigh in on MBX.

Sign in to join the discussion.

Scroll to Top